91福利

Last Tuesday 31^st of May the first European Parliament Interest Group on Biomedical Engineering (EPIG on BME)” was launched in the Euro Parliament. This was the result of a long collaboration between the European Alliance of Medical and Biological Engineering (EAMBES), the International Federation for Medical and Biological Engineering (IFMBE) and 3 MPs, Ms Lara Comi (EPP, Italy), Mr Nicola Caputo (S&D, Italy) and Jens Gieseke (EPP, Germany).

Photo: after the EPIG on BME Launch (from left: prof Nicolas Pallikarakis, IFMBE HTAD past-Chair, Prof Richard A Black, University of Strathclyde and Editor-in-Chief of Medical Engineering & Physics IPEM Journal, John Brennan, Medtech Europe Director Regulations & Industrial Policy, Dario Pirovano Medtech Europe Senior Regulatory Adviser, prof Birgit Glasmacher, EAMBES Past President, prof Heinrich Schima, EAMBES Fellow Chair, MP Nicola Caputo, European Parliament S&D, prof Jary Hyttinen, EAMBES president, dr Leandro Pecchia, IFMBE HTAD Chairman and PAWG EAMBES Chairman, prof Shankar Krishnan, IFMBE Elected President, prof Jos Vander Sloten University of Leuven –Belgium, prof Marc Nyssen, IFMBE Treasurer, Adriana Velazquez, Director WHO Medical Device Unit, dr Andrel Linnenbank, EMABES General Secretary, prof Ratko Majarevich, IFMBE Past President.

Why, differently from the USA, the European Horizon 2020 does not have a dedicated space for BME? Do we want to lag behind USA and Japan in inventing the future of medicine?

With this question in mind, MPs Lara Comi (EPP) and Nicola Caputo (S&D) tabled a Parliamentary question written in collaboration with Dr Leandro Pecchia (EAMBES, IFMBE) asking to the European Commission why, and what they intend to do at this regard.

The 31^st of May there will be the launch of the European Parliament Interest Group on Biomedical Engineering. This event will see the participation of Professor Jari Hyttinen, President of EAMBES, Dr. Edgardo Maria Iozia, Rapporteur of EESC report on biomedical engineering, Dr. Adriana Velazquez, Senior Advisor and Focal Point of Medical Devices at World Health Organization, Dr Leandro Pecchia, IFMBE HTA Division Chairman, Mr. Andrzej Rys, Director Health systems, medical products and innovation DG SANTE.

Agenda

The first paper proving an association between depressed HRV and risk of falling was published on IEEE Journal of Biomedical and Health Informatics in March 2016.

Enrolling 150 subjects, we trained and tested an automatic classifier basing on Multinomial Naïve Bayes enabled to predict first-time fallers. This achieved sensitivity, specificity and accuracy rates of 72%, 61%, 68% respectively.

This was the first sutdy proving this association.

ISAHP2016

London / August 4-7, 2016

First Call for Papers

Divide, compara, aggrega et impera

Divide, compare, pool and rule

Taking decisions has never been easy, especially in complex and dynamic circumstances, in which our choices may affect people’s health, work, social and physical assets, and future life in general.

In all of history, important decision makers have based their own choices on personal experience, intuition and knowledge. Nowadays, especially when we take decisions of public relevance and interest, we are called to demonstrate that our choices are based on the best available evidence, that we acknowledge uncertainty, and that we considered the costs and risks. Today turbulent socio-economic environments make these efforts even more compelling.

The ambition of ISAHP 2016 is to explore how the AHP/ANP can be used to respond to those challenges, its strengths and weaknesses and how it can be used in combination with other Multi-Criteria Decision Making methods. In other words, the ISHAP2016 aims to demonstrate how the AHP/ANP and the community of AHP/ANP users can have a real impact on our continuously evolving global society. In conclusion, the theme of the ISHAP2016 is how this method can support decisions affecting the public interest and how its use can be improved in order to better serve society.